335 related articles for article (PubMed ID: 19589113)
1. Upstream therapy of atrial fibrillation.
Smit MD; Van Gelder IC
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):763-78. PubMed ID: 19589113
[TBL] [Abstract][Full Text] [Related]
2. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
3. [Upstream therapy of atrial fibrillation in patients with heart failure].
Alboni P; Gianfranchi L; Pacchioni F
G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
[TBL] [Abstract][Full Text] [Related]
4. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
Disertori M; Zeni P; Quintarelli S; Bonmassari R
G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
[TBL] [Abstract][Full Text] [Related]
5. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
6. Drug therapy for atrial fibrillation.
Conway EL; Musco S; Kowey PR
Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
[TBL] [Abstract][Full Text] [Related]
7. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Savelieva I; Camm J
Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
[TBL] [Abstract][Full Text] [Related]
8. Non-antiarrhythmic drugs in atrial fibrillation: a review of non-antiarrhythmic agents in prevention of atrial fibrillation.
Lally JA; Gnall EM; Seltzer J; Kowey PR
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1222-8. PubMed ID: 17553070
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of renin angiotensin system inhibitors and bepridil is useful for maintaining sinus rhythm in patients with atrial fibrillation.
Kawamura M; Ito H; Onuki T; Miyoshi F; Minoura Y; Asano T; Tanno K; Kobayashi Y
J Cardiol; 2007 Dec; 50(6):343-50. PubMed ID: 18186308
[TBL] [Abstract][Full Text] [Related]
10. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
Elahi MM; Flatman S; Matata BM
Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
[TBL] [Abstract][Full Text] [Related]
11. [New strategies in the treatment of atrial fibrillation].
Tamargo Menéndez J
An R Acad Nac Med (Madr); 2007; 124(2):305-16; discussion 316-8. PubMed ID: 18069598
[TBL] [Abstract][Full Text] [Related]
12. Statins and atrial fibrillation: do we need a further study?
Savelieva I; Camm AJ
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):801-4. PubMed ID: 21809959
[No Abstract] [Full Text] [Related]
13. Novel pharmacological therapies for atrial fibrillation.
Bagwe S; Leonardi M; Bissett J
Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
[TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation.
Baker WL; White CM
Conn Med; 2007 Apr; 71(4):205-9. PubMed ID: 17487005
[No Abstract] [Full Text] [Related]
15. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 May; 13(5):610-25. PubMed ID: 21515595
[TBL] [Abstract][Full Text] [Related]
16. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker].
Goette A
Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445
[No Abstract] [Full Text] [Related]
17. Valsartan and recurrent atrial fibrillation.
Tomoda H
N Engl J Med; 2009 Jul; 361(5):532-3; author reply 533. PubMed ID: 19645082
[No Abstract] [Full Text] [Related]
18. Pharmacotherapy of atrial fibrillation: an old option with new possibilities.
Janko S; Dorwarth U; Hoffmann E
Expert Opin Pharmacother; 2008 Apr; 9(6):913-25. PubMed ID: 18377335
[TBL] [Abstract][Full Text] [Related]
19. Structural remodeling in atrial fibrillation.
Corradi D; Callegari S; Maestri R; Benussi S; Alfieri O
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):782-96. PubMed ID: 18852714
[TBL] [Abstract][Full Text] [Related]
20. Upstream effect for atrial fibrillation: still a dilemma?
Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
